Merck’s Keytruda may be the most talked about drug facing loss of exclusivity but it’s far from the only one, as several of ...

1) Becoming a green low-cost (Capex and Opex) manufacturer of Fumed Silica using the FUMED SILICA REACTOR, a proprietary ...

Vestel has become the first Turkish company to generate revenue from Standard Essential Patent (SEP) licensing, which covers ...

A company that operates a battery production facility in Dayton may have a solution to make electric vehicle (EV) batteries ...

Milestone's NDA for CARDAMYST is currently under review at the FDA with a Prescription Drug User Fee Act (PDUFA) target date of March 27, 2025. The Company continues to advance commercial preparations ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) ("Acurx" or the "Company"), a late-stage biopharmaceutical company developing a new class of small molecule antibiotics for difficult-to-treat bacterial ...

In 2025, as SaaS leaders look to realize the aforementioned benefits of AI, they will also need to ensure they have aligned ...

SINTX Technologies (SINT) announced the issuance of U.S. Patent No. 12,239,761 by the U.S. Patent and Trademark Office, or USPTO. This newly ...

The FDA is mired in uncertainty with some staffers losing their jobs over the weekend and more potentially to come, vaccines ...

Q4 2024 Earnings Call Transcript February 18, 2025 Adeia Inc. beats earnings expectations. Reported EPS is $0.47, ...

Unity of invention and double patenting law and practice in Canada can create challenges for patent applicants. For example, ...

A Constitution Bench of the Supreme Court on Wednesday reserved its judgment on the questions of whether the power of a court ...